About Us

Home » About Us » Jonathan Synett

Jonathan Synett

A photograph of Jonathan Synett

Jonathan Synett 
Director 

Jonathan is the Chief Investment Officer of NCL Technology Ventures, a specialist investment management firm focussing on high growth technology companies in the healthcare space. Jonathan manages both of NCL’s technology funds and sits on the Board of a number of development stage businesses. 
 
Jonathan has over 20 years experience working with and investing in early stage, high growth businesses. As well as being the founder of a high growth health and wellness business, he has managed investment portfolios for two Ultra High Net Worth’s, investing across a variety of sectors including technology, renewables and healthcare. 
 
He holds a degree in Economics and History from Manchester University and an INSEAD MBA. Jonathan now manages both of NCL’s technology funds and sits on the Board of a number of venture stage businesses.

Azadyne is a pre-clinical stage company exploiting a novel drug target and pathway that provides a paradigm shift in the treatment of autoimmune diseases